![Menzo Havenga](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Menzo Havenga
Chief Executive Officer at Batavia Biosciences BV
Profile
Menzo Havenga is the founder of Batavia Biosciences BV, which is founded in 2010, where he holds the title of President & Chief Executive Officer.
He was also a Research Director at Introgene BV from 1994 to 2001.
Dr. Havenga was the Managing Director at Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk.
He was also the Vice President-Research & Development at Crucell NV from 2001 to 2007.
Dr. Havenga holds a doctorate degree from the University of Leiden.
Menzo Havenga active positions
Companies | Position | Start |
---|---|---|
Batavia Biosciences BV
![]() Batavia Biosciences BV Pharmaceuticals: MajorHealth Technology Batavia Biosciences BV provides biopharmaceutical process development services. It offers biopharmaceutical materials research and pre-clinical study services for biopharmaceutical clients. The firm services cover candidate selection, production of research materials, upstream and downstream process development, assay development, product characterization and clinical manufacturing and release. The company was founded in 2010 and is headquartered in Leiden, the Netherlands. | Chief Executive Officer | 2010-10-19 |
Former positions of Menzo Havenga
Companies | Position | End |
---|---|---|
Crucell NV
![]() Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Chief Tech/Sci/R&D Officer | 2006-12-31 |
Introgene BV | Chief Tech/Sci/R&D Officer | 2000-12-31 |
Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk
![]() Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk Miscellaneous Commercial ServicesCommercial Services Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk provides scientific services. It includes research and consultancy for government, businesses and organizations. The company was founded in 1932 and is headquartered in Delft, Netherlands. | Corporate Officer/Principal | - |
Training of Menzo Havenga
University of Leiden | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Batavia Biosciences BV
![]() Batavia Biosciences BV Pharmaceuticals: MajorHealth Technology Batavia Biosciences BV provides biopharmaceutical process development services. It offers biopharmaceutical materials research and pre-clinical study services for biopharmaceutical clients. The firm services cover candidate selection, production of research materials, upstream and downstream process development, assay development, product characterization and clinical manufacturing and release. The company was founded in 2010 and is headquartered in Leiden, the Netherlands. | Health Technology |
Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk
![]() Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk Miscellaneous Commercial ServicesCommercial Services Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk provides scientific services. It includes research and consultancy for government, businesses and organizations. The company was founded in 1932 and is headquartered in Delft, Netherlands. | Commercial Services |
Crucell NV
![]() Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Health Technology |
Introgene BV | Health Technology |
- Stock Market
- Insiders
- Menzo Havenga